CN1809288A - 体重管理饮料 - Google Patents
体重管理饮料 Download PDFInfo
- Publication number
- CN1809288A CN1809288A CNA200480017407XA CN200480017407A CN1809288A CN 1809288 A CN1809288 A CN 1809288A CN A200480017407X A CNA200480017407X A CN A200480017407XA CN 200480017407 A CN200480017407 A CN 200480017407A CN 1809288 A CN1809288 A CN 1809288A
- Authority
- CN
- China
- Prior art keywords
- composition
- weight
- beverage
- account
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 87
- 230000037221 weight management Effects 0.000 title claims abstract description 32
- 239000000203 mixture Substances 0.000 claims abstract description 184
- 235000008504 concentrate Nutrition 0.000 claims abstract description 30
- 230000036186 satiety Effects 0.000 claims abstract description 14
- 235000019627 satiety Nutrition 0.000 claims abstract description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 54
- 239000000796 flavoring agent Substances 0.000 claims description 51
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical group CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 50
- 235000019634 flavors Nutrition 0.000 claims description 45
- 244000269722 Thea sinensis Species 0.000 claims description 44
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 claims description 31
- 235000011987 flavanols Nutrition 0.000 claims description 31
- 150000002206 flavan-3-ols Chemical class 0.000 claims description 29
- 239000003795 chemical substances by application Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 27
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 25
- 229960001948 caffeine Drugs 0.000 claims description 25
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 25
- 235000009569 green tea Nutrition 0.000 claims description 25
- 235000010447 xylitol Nutrition 0.000 claims description 25
- 239000011575 calcium Substances 0.000 claims description 24
- 229910052791 calcium Inorganic materials 0.000 claims description 24
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 24
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 23
- 239000000811 xylitol Substances 0.000 claims description 23
- 229960002675 xylitol Drugs 0.000 claims description 23
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 23
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 22
- 239000007787 solid Substances 0.000 claims description 19
- 238000004519 manufacturing process Methods 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 16
- 239000003963 antioxidant agent Substances 0.000 claims description 15
- 230000003078 antioxidant effect Effects 0.000 claims description 15
- 235000006708 antioxidants Nutrition 0.000 claims description 15
- 229960005070 ascorbic acid Drugs 0.000 claims description 15
- 230000000694 effects Effects 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- 235000010323 ascorbic acid Nutrition 0.000 claims description 14
- 239000011668 ascorbic acid Substances 0.000 claims description 14
- 239000000835 fiber Substances 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 13
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 12
- 229930003268 Vitamin C Natural products 0.000 claims description 12
- 235000019154 vitamin C Nutrition 0.000 claims description 12
- 239000011718 vitamin C Substances 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 10
- 238000005265 energy consumption Methods 0.000 claims description 10
- 150000005846 sugar alcohols Polymers 0.000 claims description 10
- 235000016213 coffee Nutrition 0.000 claims description 9
- 235000013353 coffee beverage Nutrition 0.000 claims description 9
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 8
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 8
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 8
- 238000004040 coloring Methods 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 239000011159 matrix material Substances 0.000 claims description 7
- 150000003009 phosphonic acids Chemical class 0.000 claims description 7
- 235000013343 vitamin Nutrition 0.000 claims description 7
- 238000010521 absorption reaction Methods 0.000 claims description 6
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 235000015203 fruit juice Nutrition 0.000 claims description 5
- 230000002401 inhibitory effect Effects 0.000 claims description 5
- 235000013615 non-nutritive sweetener Nutrition 0.000 claims description 5
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 4
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 4
- 238000013459 approach Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 claims description 4
- 235000013322 soy milk Nutrition 0.000 claims description 4
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 claims description 3
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 claims description 3
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 3
- 235000013734 beta-carotene Nutrition 0.000 claims description 3
- 239000011648 beta-carotene Substances 0.000 claims description 3
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 3
- 229960002747 betacarotene Drugs 0.000 claims description 3
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 claims description 3
- 235000012734 epicatechin Nutrition 0.000 claims description 3
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 3
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 claims description 2
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 claims description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- 235000011037 adipic acid Nutrition 0.000 claims description 2
- 239000001361 adipic acid Substances 0.000 claims description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000001530 fumaric acid Substances 0.000 claims description 2
- 235000011087 fumaric acid Nutrition 0.000 claims description 2
- 235000012208 gluconic acid Nutrition 0.000 claims description 2
- 239000000174 gluconic acid Substances 0.000 claims description 2
- 235000011090 malic acid Nutrition 0.000 claims description 2
- 239000001630 malic acid Substances 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- 230000002596 correlated effect Effects 0.000 claims 1
- 230000004151 fermentation Effects 0.000 claims 1
- 238000000855 fermentation Methods 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 13
- 238000012423 maintenance Methods 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 235000019577 caloric intake Nutrition 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000035924 thermogenesis Effects 0.000 abstract 1
- 239000000306 component Substances 0.000 description 37
- 230000003628 erosive effect Effects 0.000 description 20
- 229960005069 calcium Drugs 0.000 description 18
- 235000001465 calcium Nutrition 0.000 description 18
- 235000013616 tea Nutrition 0.000 description 18
- 230000037396 body weight Effects 0.000 description 16
- 235000005911 diet Nutrition 0.000 description 15
- 230000037213 diet Effects 0.000 description 14
- 239000000463 material Substances 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 8
- 208000008589 Obesity Diseases 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- -1 excitant Natural products 0.000 description 8
- 230000001800 adrenalinergic effect Effects 0.000 description 7
- 159000000007 calcium salts Chemical class 0.000 description 7
- 235000019225 fermented tea Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 235000020824 obesity Nutrition 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 240000007154 Coffea arabica Species 0.000 description 6
- 208000031773 Insulin resistance syndrome Diseases 0.000 description 6
- 235000006468 Thea sinensis Nutrition 0.000 description 6
- 235000009470 Theobroma cacao Nutrition 0.000 description 6
- 244000299461 Theobroma cacao Species 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 230000002641 glycemic effect Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 5
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 5
- 235000020279 black tea Nutrition 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 235000013355 food flavoring agent Nutrition 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 235000012631 food intake Nutrition 0.000 description 5
- 230000030136 gastric emptying Effects 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000000670 limiting effect Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000006188 syrup Substances 0.000 description 5
- 235000020357 syrup Nutrition 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000007726 management method Methods 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 238000009928 pasteurization Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 4
- 238000004260 weight control Methods 0.000 description 4
- WSWCOQWTEOXDQX-MQQKCMAXSA-M (E,E)-sorbate Chemical compound C\C=C\C=C\C([O-])=O WSWCOQWTEOXDQX-MQQKCMAXSA-M 0.000 description 3
- PFWLFWPASULGAN-UHFFFAOYSA-N 7-methylxanthine Chemical compound N1C(=O)NC(=O)C2=C1N=CN2C PFWLFWPASULGAN-UHFFFAOYSA-N 0.000 description 3
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 3
- 244000194101 Ginkgo biloba Species 0.000 description 3
- 240000003553 Leptospermum scoparium Species 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930003316 Vitamin D Natural products 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229940050390 benzoate Drugs 0.000 description 3
- 239000001362 calcium malate Substances 0.000 description 3
- 229940016114 calcium malate Drugs 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 229940094952 green tea extract Drugs 0.000 description 3
- 235000020688 green tea extract Nutrition 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 229940075554 sorbate Drugs 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 235000019166 vitamin D Nutrition 0.000 description 3
- 239000011710 vitamin D Substances 0.000 description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 description 3
- 229940046008 vitamin d Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 description 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 2
- 239000001842 Brominated vegetable oil Substances 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 description 2
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 2
- 244000130592 Hibiscus syriacus Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 229920000294 Resistant starch Polymers 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 239000004376 Sucralose Substances 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000019323 brominated vegetable oil Nutrition 0.000 description 2
- 150000001669 calcium Chemical class 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- SEAWWLNESDNCGI-UHFFFAOYSA-K dicalcium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O SEAWWLNESDNCGI-UHFFFAOYSA-K 0.000 description 2
- WTCHPRSVXSCIDZ-UHFFFAOYSA-J dicalcium;2-hydroxypropane-1,2,3-tricarboxylate;2-hydroxypropanoate Chemical compound [Ca+2].[Ca+2].CC(O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WTCHPRSVXSCIDZ-UHFFFAOYSA-J 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 229960001484 edetic acid Drugs 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 235000010241 potassium sorbate Nutrition 0.000 description 2
- 239000004302 potassium sorbate Substances 0.000 description 2
- 229940069338 potassium sorbate Drugs 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000021254 resistant starch Nutrition 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 235000014214 soft drink Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000019408 sucralose Nutrition 0.000 description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- 235000012976 tarts Nutrition 0.000 description 2
- 229960004559 theobromine Drugs 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- GMRQFYUYWCNGIN-ZVUFCXRFSA-N 1,25-dihydroxy vitamin D3 Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-ZVUFCXRFSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- 244000235603 Acacia catechu Species 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 108060003345 Adrenergic Receptor Proteins 0.000 description 1
- 102000017910 Adrenergic receptor Human genes 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000099147 Ananas comosus Species 0.000 description 1
- 235000007119 Ananas comosus Nutrition 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 241001444063 Aronia Species 0.000 description 1
- 244000189799 Asimina triloba Species 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- IWXAZSAGYJHXPX-BCEWYCLDSA-N Bisbentiamine Chemical compound C=1C=CC=CC=1C(=O)OCC/C(SS\C(CCOC(=O)C=1C=CC=CC=1)=C(/C)N(CC=1C(=NC(C)=NC=1)N)C=O)=C(/C)N(C=O)CC1=CN=C(C)N=C1N IWXAZSAGYJHXPX-BCEWYCLDSA-N 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000209507 Camellia Species 0.000 description 1
- 235000014143 Camellia sinensis var assamica Nutrition 0.000 description 1
- 240000008441 Camellia sinensis var. assamica Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 244000228088 Cola acuminata Species 0.000 description 1
- 235000010205 Cola acuminata Nutrition 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- 244000008991 Curcuma longa Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 208000032928 Dyslipidaemia Diseases 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000360590 Erythrites Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- 244000141009 Hypericum perforatum Species 0.000 description 1
- 206010060378 Hyperinsulinaemia Diseases 0.000 description 1
- 240000004343 Indigofera suffruticosa Species 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 244000270834 Myristica fragrans Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 235000003283 Pachira macrocarpa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 244000288157 Passiflora edulis Species 0.000 description 1
- 241001130943 Phyllanthus <Aves> Species 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000508269 Psidium Species 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- ZZMNWJVJUKMZJY-AFHBHXEDSA-N Sesamolin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-AFHBHXEDSA-N 0.000 description 1
- ZZMNWJVJUKMZJY-UHFFFAOYSA-N Sesamolin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3OC2=CC=C3OCOC3=C2)=C1 ZZMNWJVJUKMZJY-UHFFFAOYSA-N 0.000 description 1
- 235000000485 Smilax china Nutrition 0.000 description 1
- 244000261559 Smilax china Species 0.000 description 1
- 235000003205 Smilax rotundifolia Nutrition 0.000 description 1
- 240000009022 Smilax rotundifolia Species 0.000 description 1
- 239000004283 Sodium sorbate Substances 0.000 description 1
- 235000014459 Sorbus Nutrition 0.000 description 1
- 241001092391 Sorbus Species 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 239000000150 Sympathomimetic Substances 0.000 description 1
- 235000014364 Trapa natans Nutrition 0.000 description 1
- 240000001085 Trapa natans Species 0.000 description 1
- 241000157352 Uncaria Species 0.000 description 1
- 244000081822 Uncaria gambir Species 0.000 description 1
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 description 1
- 244000291414 Vaccinium oxycoccus Species 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000323 adipokinetic effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 210000003486 adipose tissue brown Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000001539 anorectic effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 235000021407 appetite control Nutrition 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 102000016959 beta-3 Adrenergic Receptors Human genes 0.000 description 1
- 108010014502 beta-3 Adrenergic Receptors Proteins 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229950009892 bisbentiamine Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000004301 calcium benzoate Substances 0.000 description 1
- 235000010237 calcium benzoate Nutrition 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000011116 calcium hydroxide Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 235000012255 calcium oxide Nutrition 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229960001714 calcium phosphate Drugs 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- MCFVRESNTICQSJ-RJNTXXOISA-L calcium sorbate Chemical compound [Ca+2].C\C=C\C=C\C([O-])=O.C\C=C\C=C\C([O-])=O MCFVRESNTICQSJ-RJNTXXOISA-L 0.000 description 1
- 235000010244 calcium sorbate Nutrition 0.000 description 1
- 239000004303 calcium sorbate Substances 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- GUPPESBEIQALOS-UHFFFAOYSA-L calcium tartrate Chemical compound [Ca+2].[O-]C(=O)C(O)C(O)C([O-])=O GUPPESBEIQALOS-UHFFFAOYSA-L 0.000 description 1
- 239000001427 calcium tartrate Substances 0.000 description 1
- 235000011035 calcium tartrate Nutrition 0.000 description 1
- HZQXCUSDXIKLGS-UHFFFAOYSA-L calcium;dibenzoate;trihydrate Chemical compound O.O.O.[Ca+2].[O-]C(=O)C1=CC=CC=C1.[O-]C(=O)C1=CC=CC=C1 HZQXCUSDXIKLGS-UHFFFAOYSA-L 0.000 description 1
- 235000020934 caloric restriction Nutrition 0.000 description 1
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000007958 cherry flavor Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229940099898 chlorophyllin Drugs 0.000 description 1
- 235000019805 chlorophyllin Nutrition 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 208000012696 congenital leptin deficiency Diseases 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000013410 fast food Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000004190 glucose uptake Effects 0.000 description 1
- 235000010985 glycerol esters of wood rosin Nutrition 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000003451 hyperinsulinaemic effect Effects 0.000 description 1
- 201000008980 hyperinsulinism Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000006362 insulin response pathway Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 150000002506 iron compounds Chemical class 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 230000001483 mobilizing effect Effects 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229940105623 neo-synephrine Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000001702 nutmeg Substances 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000004482 other powder Substances 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 235000011176 polyphosphates Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000004300 potassium benzoate Substances 0.000 description 1
- 235000010235 potassium benzoate Nutrition 0.000 description 1
- 229940103091 potassium benzoate Drugs 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 239000012744 reinforcing agent Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000009165 saligot Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- RXHIKAIVEMAPRU-JRIGQVHBSA-N sequiterpene Natural products C1=C(C)[C@@H](OC(C)=O)[C@H](O)[C@@]2(O)[C@H](C)CC[C@@H](C(C)=C)[C@H]21 RXHIKAIVEMAPRU-JRIGQVHBSA-N 0.000 description 1
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- LROWVYNUWKVTCU-STWYSWDKSA-M sodium sorbate Chemical compound [Na+].C\C=C\C=C\C([O-])=O LROWVYNUWKVTCU-STWYSWDKSA-M 0.000 description 1
- 235000019250 sodium sorbate Nutrition 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000012859 sterile filling Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001975 sympathomimetic effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 238000007738 vacuum evaporation Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/163—Liquid or semi-liquid tea extract preparations, e.g. gels or liquid extracts in solid capsules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/30—Artificial sweetening agents
- A23L27/33—Artificial sweetening agents containing sugars or derivatives
- A23L27/34—Sugar alcohols
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
- A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
- A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Tea And Coffee (AREA)
- Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
Abstract
本发明涉及体重管理饮料组合物和帮助维持体重的方法,该方法通过促进能量消耗(“产热”)的增加并同时增加饱腹感从而降低这些组合物的使用者的总能量摄取来进行。本文所述的组合物包括干饮料混合物、饮料浓缩品以及即可饮用形式的饮料,以便它们可在各种环境中使用。
Description
背景技术
本发明涉及可用作体重管理助手和促进消费者一般健康的饮料。本发明的饮料还有助于用于改善胰岛素抵抗综合征病症以及预防冠心病和II型糖尿病的体重管理。
该饮料含有组分如黄烷醇、兴奋剂、木糖醇、钙和抗氧化剂的混合物来提供多种功能,将它们组合以相互协助,从而提供比不包含该混合物所有组分的其它组合更好的效果和意想不到的益处。具体而言,所配制的该组合物将通过聚焦于两个基本的营养概念来减轻肥胖症,即(1)控制能量吸收和(2)增加能量消耗。
肥胖症是一种值得注意的健康危险且与多种退化性疾病有关。肥胖症和胰岛素抵抗通常伴有高胰岛素血症、葡萄糖耐受不良、高血压、血脂异常症、过早动脉粥样硬化以及冠心病和II型糖尿病的危险性增加。这一系列异常情况被称为胰岛素抵抗综合征(IRS)或代谢综合征(综合征X)。
因此,肥胖症对死亡率的影响与体重呈负相关性。在极端或病态肥胖症中,死亡率可能超过正常人1200%。许多超重的人把他们的肥胖症归因于吃得太多、缺少食欲控制和/或缺少有效的身体活动。体重管理是一种复杂的现象,通常根据营养平衡而变化。由食物摄取引入的和生物体用于维持生命机能(代谢、呼吸、温度调节、运动等)而使用的能量的量决定能量平衡,假如长期为正,则不可避免地导致体重增加和肥胖症。
同样,以限制热量和增加身体活动为形式的生活方式的改变是最常见的用于治疗患有IRS的肥胖个体的方式。已经表明:在IRS患者中,5-7%体重减轻使发展成糖尿病的危险降低58%。(Knowler WC,Barrett-ConnorE.,Fowler SE,Hamman RF,Lachin JM,Walker EA,Nathan DM:Diabetes Prevention Program Research Group:Reduction in the incidenceof type 2 diabetes with lifestyle intervention or metformin.N.Engl.J.Med.346:393-403,2002,其内容引入本文作为参考)。
近几年已经清楚地表明仅采用控制体重的饮食是没有效的。还有,应用药物或化学品来治疗肥胖症也不是很有效,因为它们显示出明显的和使人不愉快的副作用。
一些与体重控制有关的中心问题如下:
a)作为一种防御机制,通过低热量饮食获得的体重减轻使食物的诱惑力增加。随后,暂时的体重减轻通常被快速且往往是不受控制的体重增加所代替。
b)脂肪从脂肪沉积中的动员及其在代谢过程的优先使用难以发生,这代表了最难以面对的问题。
众所周知:表没食子儿茶精没食子酸盐(EGCG)——绿茶中的主要黄烷醇——可以减少食物摄入并引起体重减轻(PCT申请WO 01/60319)。
PCT申请WO 02/078469承认:虽然某些成分,例如儿茶精(catechin)和咖啡因,能用于增加能量和增强能量利用的目的,但含有那些成分的产品倾向于是高糖的,而且糖可能促进与血糖水平过量、其迅速消除、胰岛素反应引发以及脂肪氧化最终不足/减少有关的问题。
在努力克服早先的体重管理组合物的问题的过程中,本发明教导了一种组合物,该组合物包含(a)多元醇或纤维;(b)黄烷醇和(c)钙,它在哺乳动物的身体中协同地提供增强的脂肪代谢并抑制脂肪储存。本发明的组合物有效地调节身体系统内的葡萄糖,从而为身体系统提供能量而不引起全身脂肪沉积。
木糖醇是一种戊糖醇,其被证明在饮食控制方面是一种潜在重要的治疗剂。Shafer等研究了木糖醇对复合餐的固体食物组分胃排空的影响(Am.J.Clin.Nutr.,1987,45:744-747)。在摄食25克木糖醇后,胃排空明显延长。他们还证明了:用水预先口服25克木糖醇后,食物摄入导致摄入690±45千卡的热量,与对照的920±60千卡热量相比,卡路里(calories)减少25%。
还有证据表明:木糖醇有利于充当适于糖尿病应用的甜味剂,因为它促进低的血糖指数(参见美国专利5,204,115)。木糖醇的其它优点包括减少或甚至是消除牙齿附着物(dental carries)(参见美国专利5,223,303)。
现代研究还已经表明:有效的体重管理不仅需要减少通过摄入脂肪和糖而引入生物体的能量的量(低脂肪/低热量饮食),而且还需要有动员所储存脂肪的方式,即,使用有产热作用的物质。
已经证明饮食中的钙有助于脂肪储存的动员和产热输出。增加饮食中的钙引起1,25-二羟维生素D的调节,1,25-二羟维生素D被证明能在小鼠体内缺少热量限制的情况下减少脂肪质量。更有趣的是,饮食中钙的增加使1,25-二羟维生素D的含量降低,从而导致在热量限制期间脂肪质量和体重增加明显减少以及脂肪损耗。这种饮食中钙的抗肥胖作用和支持该结论的人类临床和流行病学的证据已经由Zemel作了综述(Journal of theAmerican College of Nutrition,第21卷,第2期,146S-151S[2002])。产热是这样一种代谢过程:生物体尤其是在肌肉和脂肪组织中(具体指褐脂肪组织)采用可利用的脂肪沉积作为能源来进行热生成。产热输出增加有利于维持体重,甚至在食物摄入量没有显著变化时如此。产热水平根据遗传预定的方式而在个体之间不同,出于这个原因,体重在个体之间也不同,而与饮食设置的能量限制无关。
产热是由肾上腺素能系统通过β-3-肾上腺素能受体控制的过程。因此,产热水平可通过肾上腺素能样物质(肾上腺素能或拟交感神经物质)如麻黄碱、昔奈福林、苯丙胺、去氧肾上腺素等而改变。肾上腺素能样化合物单独激活产热时不是非常有活性,因此它们通常与中枢神经系统兴奋剂一起使用,如甲基黄嘌呤:咖啡因、茶碱和可可碱,它们与肾上腺素能物质有协同作用。
与该途径有关的主要问题包括以下事实:肾上腺素能物质与不同于β-3受体的肾上腺素能受体相互作用时产生明显的副作用,尤其是在心脏-循环水平上的副作用,尤其在高血压和临界性高血压患者中不推荐施用它们,并且可能导致严重的不良反应。在有些情形下,许多受益于产热刺激作用的超重个体还是高血压患者。由于反跳现象的出现,在所有临界性高血压的情况下将避免同时使用降压药。因此,可以避免在体重控制管理中所用的肾上腺素能物质的副作用的天然备选方案将是有利的。
另一个问题在于下述事实:仅使用产热物质对长期有效的体重管理是不足够的。因此,需要同时施用其它活性成分。例如,用于体重控制的物质之一是食物纤维,它能提供一定程度的饱腹感和改善胃排空。不过这种补充物有时分开施用,因为假如与其它营养素一起施用可干扰它们的吸收。
总之,需要一种体重管理方法和目的在于能量消耗及能量吸收的源自易获得来源的组合物。饮食和锻炼也许是用于体重控制的最常建议的医学建议。符合这种控制能量吸收及增加能量输出的概念的饮食现在能克服现有组合物的弊端并本发明中给出。
发明概述
本发明现在提供了一种组合物,其包括提供下列功能的成分的组合:(1)减少热值,(2)增加产热输出,(3)脂肪动员及利用的代谢调节,和(4)增加饱腹感,以实现活体体重管理和控制的最终目标。
本发明的体重管理饮料组合物和方法通过同时使用至少三种成分来帮助维持体重,每种成分提供一种独特的和不同的功能,并且显然伴有对体重管理的正性作用。这种所得的多障碍途径表现出对体重管理的协同正性作用。本文中所述的饮料组合物包括饮料浓缩品、干混合物和即可饮用形式的饮料,允许在各种环境中使用。
这类体重管理饮料组合物有利地包含多元醇(如木糖醇)或纤维、钙以及黄烷醇、兴奋剂和抗氧化剂三者中的至少一种,其以协同的量存在,以致该组合物的食用者获得增加的能量消耗和增加的饱腹感以降低他们额外食用的欲望,从而有助于食用者的综合体重管理。
本发明还涉及多种人的体重管理方法,包括在人类中抑制饥饿感或获得增加的能量消耗及增加的饱腹感以降低他们额外食用欲望的方法,由此有助于他们的体重管理。本发明还涉及通过管理个人体重来改善胰岛素抵抗综合征病症的方法。当该组合物为饮料浓缩品和/或干混合物时,它可以在食用前通过与例如水或其它液体混合来重构。此外,该组合物可以被发酵。
优选实施方案的详述
本发明涉及优选以饮料形式被食用的组合物,它使能量消耗增加、胃排空时间延长并提供饱腹感,从而促进产生食用者更期望的体重,同时保持食用者的一般健康和良好状态。
如本文所用的术语“饮料”表示一倍浓度的即可饮用(换言之,可饮用)的组合物。如本文所用的“饮料浓缩品”指在食用前需要添加液体如水来重构的饮料浓缩液体。“饮料混合物”指在食用前需要添加液体如水来重构的饮料干混合物或脱水形式。
如本文所用的术语“茶类材料”指这样的茶类:它包括从包括Camelliasinensis和Camellia assamica在内的Camellia属获得的材料,例如,新采集的茶叶、采集后立即干燥的新鲜茶叶、在干燥以使存在的任何酶失活之前已进行热处理的新鲜茶叶、未发酵茶、发酵茶、速溶绿色发酵茶、部分发酵茶叶以及这些茶叶的含水提取物。茶类材料是茶叶、它们的提取物、茶树茎及相关的其它植物原料。还可使用茶树的Phyllanthus属、Catechugambir或Uncaria科的成员。可以使用未发酵茶、部分发酵茶和发酵茶的混合物。
如本文所用的术语“茶固形物”指从茶类材料中提取的固形物。用于本发明组合物的茶类材料可能含有未氧化的未聚合的黄烷醇。
本发明的组合物包含一种或多种黄烷醇。用于所有本发明的组合物的黄烷醇可作为绿茶固形物的成分存在。红茶、水果及其它天然来源也含有这些黄烷醇,但含量较低。例如,从茶树及Catechu gambir科(钩藤科)的其它成员中提取的最常见的黄烷醇的非限制性实例包括例如儿茶精类,它包括儿茶精、表儿茶精、没食子儿茶精、表没食子儿茶精、表儿茶精没食子酸盐以及表没食子儿茶精没食子酸盐。优选所用的黄烷醇为表没食子儿茶精没食子酸盐(“EGCG”)。
或者,相同的黄烷醇可通过合成或其它适宜的化学方法来制备并掺入本发明的组合物中。包括儿茶精、表儿茶精以及它们的衍生物在内的黄烷醇可自商业获得。
本发明的饮料组合物中黄烷醇的量可以变化。优选黄烷醇以占组合物重量约0.01%至约0.75%、优选0.02至0.5%的量存在。当利用来自绿茶固形物的黄烷醇时,优选提供按组合物重量计的每份最低30-200mgEGCG,更优选按已完成饮料组合物重量计的每份最低50-100mg EGCG。绿茶固形物优选以占已完成饮料组合物重量的约0.15%-10.0%、更优选0.25%-5.0%的量存在。最终绿茶固形物含量将依赖于已完成的饮料形式,也就是即可饮用的饮料、饮料浓缩品或干饮料混合物。绿茶固形物组合物将根据茶的等级、提取方法以及浓缩技术而有别。因此,要求在规定使用水平之前将茶固形物根据EGCG和咖啡因的含量进行标准化。作为总的指导原则,不管茶提取物/粉末的来源怎样,每250ml优选的最终饮料组合物将保持绿茶固形物含量等于或高于1袋充分提取茶包(金标准为每袋2.27克茶于85-90℃温和搅拌泡5分钟)等同物的含量,而同时维持可口性。
可选地或者另外地,本发明的组合物每250毫升一倍浓度的液体组合物(即可饮用形式或由饮料浓缩品或干饮料混合物重构制备)包含约1毫克至约400毫克的总黄烷醇。更优选该组合物每250毫升一倍浓度的液体组合物包含约10毫克至约200毫克的总黄烷醇。最优选该组合物每250毫升一倍浓度的液体组合物包含约20毫克至约120毫克的总黄烷醇。
在本发明的所有实施方案中,黄烷醇的总量包括任何所加入的黄烷醇以及原有存在于本发明的任何其它组分(如绿茶固形物)中的任何黄烷醇。
不意欲受理论限制,发明人已经意欲协同地合并黄烷醇组分对产热输出的已知刺激作用与本发明组合物中木糖醇和/或纤维及钙组分的饱腹感和脂肪动员作用,以促进体重管理而同时增强抗氧化能力来促进一般健康。而且,黄烷醇组分与其它组分相互作用,以控制方式引起血糖响应来稳定血糖,从而为使用者提供能量而不需要某些高血糖的糖类如蔗糖和葡萄糖。因此,在摄取该组合物时,一种或多种黄烷醇将促进能量的开始,尤其是维持。
本发明的组合物进一步包含还可促进产热的兴奋剂。如本领域所公知的,兴奋剂可从天然来源提取获得或者可合成生产。兴奋剂的非限制性实例包括甲基黄嘌呤,例如咖啡因、可可碱、茶碱、capsinoids、capsaicinoids和木酚素(芝麻素、表芝麻素和芝麻林素。另外,已经分离或合成很多其它黄嘌呤衍生物,它们可用作本发明组合物中的兴奋剂。例如参见,Bruns,Biochemical Pharmacology,第30卷,第325-333页(1981)。优选使用这些材料的天然来源。优选兴奋剂以占组合物重量的约0.01%至约0.5%的量存在。
最优选的甲基黄嘌呤兴奋剂为咖啡因。咖啡因可从前面提到的植物和它们的废弃物中获得,或者可以经合成制备。咖啡因优选的植物来源可以作为咖啡因的全部来源或部分来源利用,包括绿茶固形物、绿茶提取物、巴西可可、巴拉圭茶提取物、红茶、可拉果、可可以及咖啡。如本文所用的绿茶固形物、绿茶提取物、巴西可可、咖啡以及巴拉圭茶提取物是咖啡因最优选的植物来源,最优选绿茶固形物、绿茶提取物和巴拉圭茶提取物。除用作咖啡因来源之外,绿茶固形物还有另外的好处,它是如以前详述的黄烷醇的来源。巴拉圭茶提取物可能具有食欲抑制作用的其它益处,为此也可以包括在内。在本发明的任何实施方案中,咖啡因的总量包括天然存在于茶固形物、调味剂、植物和任何其它组分之中的咖啡因和任何所加入的咖啡因的量。
优选咖啡因以约0.01至约0.5%的量存在。更优选它以约0.02至约0.3%的量存在。尽管更大的量可提供更大的兴奋作用,但它们也给饮料提供了较不需要的味道。这可以通过添加人造甜味剂来弥补,以使饮料的最终味道是可口的。
本发明的组合物包含多元醇如木糖醇(一种戊糖糖醇)或纤维。在化学上,多元醇定义为由碳水化合物通过将醛或酮部分还原为伯或仲羟基而获得的多元醇。施用有效量的木糖醇能促进饱腹感,由此在进餐或快餐时能控制所述动物、如哺乳动物的食欲和/或减少食物摄入。这种作用被认为与能量消耗增加(产热)协同起作用,以促进体重维持/损失。与包含非糖醇碳水化合物如葡萄糖或蔗糖的饮料相比,它还能减少饮料的热值和降低血糖指数。
木糖醇优选以占组合物重量的约1%至约90%、优选约2至85%、更优选约3至83%的量存在。因此,当用木糖醇配制时,本发明的体重管理饮料提供比用纯蔗糖增甜的产品低40-60%的卡路里,并且由于其较低的血糖指数,因而较好地适于糖尿病患者食用。尽管优先使用木糖醇,但可以使用其它多元醇,包括山梨醇、赤藓醇、甘露醇和拉克替醇。
当多元醇的应用由于技术原因而不切实际时,还可以使用纤维来产生饱腹感和调节胃排空。这种特定的功能可见于诸如菊糖、果糖低聚糖、聚葡萄糖和/或衍生的麦芽糊精、抗性淀粉(resistant starch)或其混合物的纤维。典型的功能性浓度为每份1克至多达30克。
在本发明的即可饮用饮料、饮料浓缩品和饮料混合物中包含有效的饮食钙源。它在多种功能中起作用,包括其作为由上述黄烷醇和兴奋剂提供的产热效果的增强剂。不过,更关键的是,饮食中的钙已被证明有助于脂肪储存(特别是内脏脂肪组织)的动员和利用。增加饮食中的钙会引起循环1,25-二羟维生素D的含量降低,导致在热量限制期间脂肪质量和体重增加的明显减少以及脂肪损耗。这些观察结果对体重减轻和管理来说是至关重要的。这种饮食中钙的抗肥胖作用和支持该结论的人类临床和流行病学的证据已经由Zemel作了综述(Journal of the American College of Nutrition,第21卷,第2期,146S-151S[2002])。
优选的钙源例如包括奶钙、柠檬酸钙-乳酸钙、氨基酸螯合钙、碳酸钙、氧化钙、氢氧化钙、硫酸钙、氯化钙、磷酸钙、磷酸氢钙、磷酸二氢钙、柠檬酸钙、苹果酸钙、酒石酸钙、葡萄糖酸钙、calcium realate、calciumtantrate和乳酸钙,尤其是柠檬酸钙-苹果酸钙。柠檬酸钙-乳酸钙的形成在Jacobson等人的美国专利6,036,985中有描述。柠檬酸钙-苹果酸钙的形成在例如美国专利5,670,344或5,612,026中有描述。本发明优选的组合物将包含占产品重量的约0.01%至约15.0%、更优选约0.1至12%、最优选约0.5%至约10.0%的钙。
本发明的饮料还可以是符合本领域技术人员已知的标准的发酵饮料。
本发明的饮料还包含至少一种抗氧化维生素。这种抗氧化剂可以是维生素如维生素C、维生素A棕榈酸酯、双苯酰硫胺、核黄素、盐酸吡哆醇、维生素B12、抗坏血酸钠、维生素D3、烟酰胺、泛酸钙、叶酸、生物素、双酒石酸胆碱等。在这些维生素中,维生素C尤其合乎需要并为优选。
如本文所用的“维生素C”包括一种或多种L-抗坏血酸(本文还称为抗坏血酸)以及它们的包括盐和酯在内的生物等效形式。例如,本文中抗坏血酸钠被认为是维生素C。另外,有许多公知的维生素C的酯,包括抗坏血酸醋酸酯。维生素C的脂肪酸酯是脂溶性的,并且可提供抗氧化作用。
维生素C可以以任何形式使用,例如,游离形式或微囊形式。在本发明中,高度优选使用游离的维生素C,例如抗坏血酸。
优选本发明的组合物包含占产品重量的约0.01%至约1%、更优选0.05%至约0.5%、最优选约0.1%至约0.5%的维生素C。
本发明的组合物还可包含其它任选的组分,这些组分增强例如它们在促进产热、提供感官特性和营养特性中效力的组分。例如,一种或多种酸化剂、着色剂、低热量甜味剂、调味剂、防腐剂、乳化剂、油类、碳酸化(carbonation)组分等可包含在本发明的组合物中。这些任选的组分可以分散、溶解或以其它方式掺入本发明的组合物中。这些组分可以加入本发明的组合物中,条件是它们基本不防碍饮料组合物的性质,尤其是提供能量和精神警戒的性质。适用于本发明的任选组分的非限制性实例在下文给出。
本发明的组合物任选但优选地还包含一种或多种酸化剂。可使用一定量的酸化剂来维持组合物的pH。本发明的组合物的pH优选为约2至约8,更优选约2至约5,甚至更优选约2至约4.5,最优选约2.7至约4.2。饮料的酸度可通过已知和常规的方法调至并维持在必要范围之内,例如应用一种或多种酸化剂。通常,在上述范围内的酸度是抑制微生物的最大酸度与达到所期望饮料香味的最佳酸度之间的平衡值。
有机和无机可食用的酸可用来调节饮料的pH。这些酸可以以未离解的形式或以各自的盐形式存在,例如磷酸氢二钾或钠、磷酸二氢钾或钠。优选的酸为可食用的有机酸,包括柠檬酸、膦酸、苹果酸、富马酸、己二酸、葡糖酸、酒石酸、抗坏血酸、乙酸或磷酸或它们的混合物。最优选的酸为柠檬酸和膦酸。优选柠檬酸和膦酸分别以约0.05%至约0.5%和约0.005%至约0.05%的量存在。更优选柠檬酸和膦酸分别约0.125%至约0.35%和约0.01%至约0.03%的量存在。
酸化剂还可以用作抗氧化剂或金属螯合剂以稳定饮料组分。常用抗氧化剂的实例包括但不局限于抗坏血酸、EDTA(乙二胺四乙酸)以及它们的盐。
少量的一种或多种着色剂可以用于本发明的组合物中。优选使用β-胡萝卜素。可以使用核黄素和FD&C染料(例如,#5黄、#2蓝、#40红)和/或FD&C色淀。通过将色淀加入其它粉末成分中,所有颗粒,尤其是有色铁化合物,被完全和均匀地着色,获得均匀着色的饮料混合物。
另外,可以使用FD&C染料或FD&C色淀染料与其它常规食物和食物着色剂的组合。另外,可以使用其它天然着色剂,包括例如叶绿素和叶绿酸以及水果、蔬菜和/或植物如葡萄、红醋栗、腺肋花楸(Aronia)、胡萝卜、甜菜、红甘蓝和木槿的提取物。对于“全天然”饮料产品优选天然着色剂。
着色剂的用量将有所变化,这取决于所用着色剂和成品中期望的颜色强度。其量可由本领域普通技术人员容易地决定。通常,如果使用的话,着色剂应占组合物重量的约0.0001%至约0.5%、优选约0.001%至约0.1%、最优选约0.004%至约0.1%。
适于糖尿病患者应用的甜味剂是血糖指数小于50的甜味剂,其中血糖指数是基于相对于葡萄糖摄取的比较血糖响应值。方法学参见Jenkins等人的“食物血糖指数:碳水化合物交换的生理学基础”(Glycemic Index ofFoods:A Physiological Basis for Carbohydrate Exchange,34 TheAmerican Journal of Clinical Nutrition,362,1982年3月)。为了达到这些值,当一种或多种低热量甜味剂用于本文时,总的低热量甜味剂优选以占组合物重量的约0.0001%至约5%、更优选约0.001%至约3%、还更优选约0.005%至约2%、甚至更优选约0.01%至约1%、最优选约0.01%至约0.05%的水平使用。
一种或多种调味剂被推荐用于本发明以增强其适口性。任何天然的或合成的调味剂都可用于本发明。例如,本发明可使用一种或多种植物和/或水果调味剂。如本文所用的,该调味剂可以是合成的或天然的调味剂。
尤其优选的水果调味剂是外来调味剂和内酯调味剂,如西番莲果调味剂、芒果调味剂、菠萝调味剂、cupuacu调味剂、番石榴调味剂、可可调味剂、木瓜调味剂、桃调味剂以及杏调味剂。除这些调味剂之外,可以使用多种其它水果调味剂,如苹果调味剂、柑桔调味剂、葡萄调味剂、覆盆子调味剂、酸果蔓调味剂、樱桃调味剂等等。这些水果调味剂可以由天然来源如果汁和香味油获得,或者可以合成制备。对于“全天然”饮料优选这些天然调味剂。
优选的植物调味剂包括例如芦荟、巴西可可、人参、银杏、山楂花、木槿、蔷薇果、甘菊、薄荷、茴香、姜、甘草、莲子、五味子、锯榈、菝葜、红花、圣约翰草、姜黄、cardimom、肉豆蔻、桂皮、布枯、肉桂、茉莉、山楂果、菊花、荸荠、甘蔗、荔枝、竹笋、香草和咖啡等。这些调味剂中优选的是巴西可可、人参和银杏(ginko)。除作为兴奋剂来源之外,茶提取物和咖啡还可用作调味剂。具体而言,茶调味剂、优选绿茶或红茶调味剂(优选绿茶)任选与水果调味剂的组合具有吸引人的味道。
调味剂还可以包括多种调味剂的混合物。需要时,可将这些调味剂中的调味剂形成乳状液滴,然后分散于饮料组合物或浓缩品中。因为这些液滴的比重通常低于水,因此形成分离相,可以使用增重剂(它还可以起混浊剂的作用)来使这些乳状液滴分散于饮料组合物或浓缩品中。诸如此类的增重剂的实例是溴化植物油(BVO)和树脂酯,尤其是酯树胶。至于增重剂和混浊剂在液体饮料中应用的进一步说明,参见L.F.Green的“软饮料技术的发展”(Developments in Soft Drinks Technology),第1卷,AppliedScience Publishers Ltd.,第87-93页(1978)。通常,这些调味剂可照惯例以浓缩品或提取物获得,或者以合成生产的调味酯、醇、醛、萜和倍半萜等的形式获得。
任选在本文中额外地使用一种或多种防腐剂。优选的防腐剂包括例如山梨酸盐、苯甲酸盐和多磷酸盐防腐剂。当本文中使用防腐剂时,优选使用一种或多种山梨酸盐或苯甲酸盐防腐剂(或它们的混合物)。适用于本发明的山梨酸盐和苯甲酸盐防腐剂包括山梨酸、苯甲酸以及它们的盐,包括(但不限于)山梨酸钙、山梨酸钠、山梨酸钾、苯甲酸钙、苯甲酸钠、苯甲酸钾以及它们的混合物。尤其优选山梨酸盐防腐剂。尤其优选山梨酸钾用于本发明。
当组合物包含防腐剂时,防腐剂的含量优选占组合物重量的约0.0005%至约0.5%、更优选约0.001%至约0.4%的防腐剂,还更优选约0.001%至约0.1%、甚至更优选约0.001%至约0.05%、最优选约0.003%至约0.03%的防腐剂。在该组合物包含一种或多种防腐剂的混合物时,这类防腐剂的总浓度优选维持在这些范围之内。
本发明饮料组合物中水的用量是使饮料组合物适合作为稀释的、即可饮用饮料的量。通常,本发明的饮料或饮料组合物包含至少60%至约97%的水,更优选至少约75%的水,甚至更优选至少约80%的水,最优选至少约83%的水。
本发明的饮料组合物可以以干混合物或脱水形式提供。这些干混合物可通过在包装前将液体饮料喷雾干燥或冷冻干燥获得,或者通过将干燥成分均匀混合或聚集(agglomeration)来获得。在意欲制备这种饮料以用于食用时,它可以通过加入液体如水而简单地重构。
本发明还可以以浓缩品的形式包装。本发明的这些饮料浓缩品可以以例如糖浆和/或浓缩水溶液的形式提供。当用水或其它含水流体或液体重构或稀释浓缩品时,通常配制饮料浓缩品以提供可饮用的饮料组合物。
本发明饮料浓缩品中水的用量是适于作为浓缩品的量,通常为糖浆或浓缩水溶液的形式,在用水或其它含水液体进一步稀释后即可饮用。通常,本发明的饮料浓缩品包含20%-85%的水,优选约20%至约50%的水,最优选约20%至约40%的水。
饮料浓缩品尤其有用,因为它们由于含水量较少而可以比最终饮料产品更方便地运输和储存。在重构后,这些饮料为食用者提供了维持能量,而血液中不会出现迅速和短暂的葡萄糖水平峰。
本发明的组合物按照普通技术人员公知的方法制备。为了方便起见,随后给出制备方法的非限制性实施例。
为了举例说明,如下制备本发明的组合物:将所有组分单独或以适宜的组合形式一起溶解、分散或以其它方式混合,酌情在水中进行上述操作,用机械搅拌器搅拌,直到所有组分已经溶解或充分分散。然后酌情将所有分离的溶液和分散体合并。当使用通常对pH敏感的茶提取物时,在将茶提取物加入混合物之前用酸化剂和/或缓冲系统调至所需pH是重要的。当需要贮存期稳定的组合物时,最终混合物可以任选地、但优选地被防腐、巴氏灭菌、超巴氏灭菌、灭菌或在适宜操作条件下无菌灌装。
在制备饮料组合物时,可任选首先形成饮料浓缩品。一种制备浓缩品形式的饮料组合物的方法是从低于制备饮料组合物所用的水的需要量开始。另一种方法将是使最终制取的饮料组合物部分脱水,以除去仅一部分水和任何其它存在的挥发性液体。脱水可按众所周知的步骤如真空蒸发来完成。浓缩品可以是相对粘稠的液体形式。糖浆通常通过将适宜组分如电解质或乳剂加入饮料浓缩品来形成。然后将糖浆与水或其它含水流体混合,形成制成的饮料或制成饮料浓缩品。水与糖浆的重量比通常为约1∶1至约5∶1。
最终饮料在单份容器(瓶、罐或Tetrabriks)中装瓶或包装。优选PET或玻璃瓶在灌装巴氏灭菌、超巴氏灭菌或灭菌的饮料之前恰当进行灭菌。饮料浓缩品和饮料浓缩品将包装在单份容器和多份相同式样的容器中。
除上述饮料之外,所述的核心功能性成分可能被应用到其它饮料基质如咖啡、果汁、豆奶和普通的调味饮料中。
实施例
采用常规方法制备该本组合物的下列非限制性实施例。下述实施例用于举例说明而非以任何方式限制本发明的范围。
实施例1
一种低酸味配方的饮料组合物通过以常规方式合并下列组分来制备:
组分 Wt.%
绿茶粉 0.32
咖啡因 0.01
木糖醇 7.0
钙盐 0.9
抗坏血酸 0.06
调味剂 0.03
水 平衡量
总计 100
实施例2
一种低酸味配方的饮料组合物通过以常规方式合并下列组分来制备:
组分 Wt.%
绿茶粉 0.30
红茶粉 0.10
咖啡因 0.015
木糖醇 8.0
钙盐 0.90
抗坏血酸 0.06
调味剂 0.03
水 平衡量
总计 100
实施例3
一种高酸味配方的饮料组合物通过以常规方式合并下列组分来制备:
组分 Wt.%
绿茶粉 0.29
咖啡因 0.03
木糖醇 5.0
钙盐 0.60
抗坏血酸 0.06
柠檬酸 0.15
调味剂 0.05
水 平衡量
总计 100
实施例4
一种高酸味配方的饮料组合物通过以常规方式合并下列组分来制备:
组分 Wt.%
绿茶粉 0.30
红茶粉 0.09
咖啡因 0.04
木糖醇 6.5
钙盐 0.72
抗坏血酸 0.06
柠檬酸 0.15
调味剂 0.15
水 平衡量
总计 100
实施例5
一种奶配方组合物通过以常规方式合并下列组分来制备:
组分 Wt.%
绿茶粉 0.45
咖啡因 0.04
木糖醇 5.0
抗坏血酸 0.04
调味剂 0.10
无脂奶粉 5.5
水 平衡量
总计 100
实施例6
一种液体饮料浓缩品通过以常规方式合并下列组分来制备:
组分 Wt.%
绿茶粉 2.30
咖啡因 0.40
木糖醇 50.0
钙盐 8.00
抗坏血酸 0.60
调味剂 0.40
水 平衡量
总计 100
实施例7
一种饮料干混合物通过以常规方式混合下列组分来制备:
组分 Wt.%
绿茶粉 5.00
咖啡因 0.40
木糖醇 78.00
钙盐 12.80
抗坏血酸 0.50
调味剂 0.30
流动剂 2.00
总计 100
实施例8
一种液体饮料浓缩品通过以常规方式合并下列组分来制备:
组分 Wt.%
绿茶粉 0.35
咖啡因 0.04
Fibersol-2(可溶性纤维) 3.00
钙盐 0.40
抗坏血酸 0.03
乙酰舒泛-K 0.03
三氯蔗糖(sucralose) 0.05
调味剂 0.10
水 平衡量
总计 100
发现实施例1-8的饮料是可口和充盈的(filling)。这些饮料的食用者发现他们吃的欲望被降低,但他们进行日常活动所必需的能量没有减少。还发现:与含有食欲抑制药或类似的非天然成分的现有饮料相比,这些饮料中所用的组分更容易被接受。
Claims (30)
1.体重管理饮料组合物,包含至少三种成分,每种成分与一种具体的与体重管理正性相关的功能有关,整个组合饮料在帮助该组合物的食用者的体重管理方面通过处理两种基本的体重管理治疗途径表现出协同的有利作用,这两种途径即(a)降低能量吸收和(b)增加能量消耗。
2.权利要求1的组合物,其中第一种成分为多元醇或纤维或它们的组合,其存在的量足以提供饱腹感以抵消人消耗卡路里的欲望。
3.权利要求1的组合物,其中第二种成分为黄烷醇,其存在的量足以提供对人的产热输出的刺激作用。
4.权利要求1的组合物,其中第三种成分为兴奋剂,其存在的量足以促进人的产热。
5.权利要求1的组合物,还包含钙。
6.权利要求1的组合物,还包含一种或多种抗氧化维生素、矿物质、酸化剂;着色剂;低热量甜味剂;调味剂;或防腐剂。
7.权利要求1的组合物,其中该组合物为发酵的液体饮料。
8.体重管理饮料组合物,包含多元醇或纤维或它们的组合、钙以及黄烷醇、兴奋剂和抗氧化剂三者中的至少一种,其以协同的量存在,以致该组合物的食用者获得增加的能量消耗和增加的饱腹感以降低他们额外食用的欲望,从而有助于食用者的体重管理。
9.权利要求8的组合物,其中多元醇为占组合物重量约1%至约90%的木糖醇;纤维以0.1至30克的量存在;黄烷醇以占组合物重量约0.01%至约0.75%的量存在;兴奋剂以占组合物重量约0.01%至约0.5%的量存在。
10.权利要求8的组合物,其中抗氧化剂为维生素C。
11.权利要求10的组合物,其中维生素C以占组合物重量约0.01%至约1%的量存在。
12.权利要求8的组合物,其中黄烷醇作为绿茶固形物的组分存在。
13.权利要求8的组合物,其中黄烷醇是儿茶精、表儿茶精、没食子儿茶精、表没食子儿茶精、表儿茶精没食子酸盐以及表没食子儿茶精没食子酸盐或它们的混合物。
14.权利要求8的组合物,其中兴奋剂为咖啡因。
15.权利要求8的组合物,其中钙以占组合物重量约0.01%至约15%的量存在。
16.权利要求8的组合物,还包含一种或多种酸化剂;着色剂;非热量甜味剂;调味剂;或防腐剂。
17.权利要求16的组合物,其包含的酸化剂是柠檬酸、膦酸、苹果酸、富马酸、己二酸、葡糖酸、酒石酸、抗坏血酸、乙酸、磷酸或其混合物的酸化剂;以及着色剂β-胡萝卜素。
18.权利要求17的组合物,其包含的酸化剂是柠檬酸和膦酸的混合物,其中柠檬酸和膦酸分别以约0.1%至约0.5%和约0.01%至约0.05%的量存在;且β-胡萝卜素以约0.005%至约0.02%的量存在。
19.权利要求8的组合物,还包含占组合物重量60%以上至约97%的水。
20.权利要求8的组合物,为含有20%至80%水的浓缩品形式,其中饮料可通过将浓缩品与含水流体混合来制备。
21.权利要求8的组合物,为含有1至10%水的干混合物或聚集粉末的形式,其中饮料可通过将干混合物或聚集粉末与含水流体混合来制备。
22.权利要求1的即可饮用的体重管理饮料组合物,具体包含:
占组合物重量约0.05%至约0.75%的绿茶固形物;
占组合物重量约0.01%至约0.25%的咖啡因;
占组合物重量约1%至约15%的木糖醇或1%至3%的纤维或它们的组合;
占组合物重量约0.01%至约1%的钙;
占组合物重量约0.01%至约1%的抗氧化维生素;和
占组合物重量约20%至约97%的水,
从而该组合物的食用者获得增加的能量消耗和增加的饱腹感以降低他们额外食用的欲望,由此帮助个人体重管理。
23.权利要求1的体重管理液体饮料浓缩组合物,具体包含:
占组合物重量约1%至约5%的绿茶固形物;
占组合物重量约0.01%至约0.4%的咖啡因;
占组合物重量约1%至约50%的木糖醇或占组合物1%至20%的纤维或它们的组合;
占组合物重量约0.01%至约10%的钙;
占组合物重量约0.01%至约1%的抗氧化维生素;和
占组合物重量约20%至约85%的水,
从而该重构组合物的食用者获得增加的能量消耗和增加的饱腹感以降低他们额外食用的欲望,由此帮助个人体重管理。
24.权利要求1的体重管理干饮料混合组合物,具体包含:
占组合物重量约0.05%至约10.0%的绿茶固形物;
占组合物重量约0.01%至约0.5%的咖啡因;
占组合物重量约1%至约90%的木糖醇或占组合物1%至约90%的纤维或它们的组合;
占组合物重量约0.01%至约15%的钙;
占组合物重量约0.01%至约1%的抗氧化维生素;和
占组合物重量约1%至约10%的水,
从而该重构组合物的食用者获得增加的能量消耗和增加的饱腹感以降低他们额外食用的欲望,由此帮助个人体重管理。
25.权利要求22的组合物,其中抗氧化剂为维生素C。
26.权利要求23的组合物,其中抗氧化剂为维生素C。
27.权利要求24的组合物,其中抗氧化剂为维生素C。
28.饮料基质,包含权利要求1的体重管理组合物和咖啡、果汁、豆奶,其中该基质被稀释或能被稀释形成饮料。
29.饮料基质,包含权利要求8的组合物和咖啡、果汁、豆奶,其中该基质被稀释或能被稀释形成饮料。
30.饮料基质,包含权利要求21的组合物和咖啡、果汁、豆奶,其中该基质被稀释或能被稀释形成饮料。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47597303P | 2003-06-04 | 2003-06-04 | |
US60/475,973 | 2003-06-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1809288A true CN1809288A (zh) | 2006-07-26 |
Family
ID=33551568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA200480017407XA Pending CN1809288A (zh) | 2003-06-04 | 2004-05-17 | 体重管理饮料 |
Country Status (11)
Country | Link |
---|---|
US (1) | US20060121158A1 (zh) |
EP (1) | EP1633209B1 (zh) |
JP (1) | JP2006526398A (zh) |
CN (1) | CN1809288A (zh) |
AT (1) | ATE440509T1 (zh) |
DE (1) | DE602004022806D1 (zh) |
ES (1) | ES2329370T3 (zh) |
MY (1) | MY141796A (zh) |
PL (1) | PL1633209T3 (zh) |
TW (1) | TWI293021B (zh) |
WO (1) | WO2004110175A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104812253A (zh) * | 2012-11-29 | 2015-07-29 | 雀巢产品技术援助有限公司 | 用具有低血糖指数的碳水化合物增加黄烷-3-醇的生物利用度 |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101001539B (zh) * | 2004-06-04 | 2012-05-30 | 视界科技有限公司 | 天然甜味剂 |
US7588931B2 (en) | 2004-11-04 | 2009-09-15 | E. I. Du Pont De Nemours And Company | High arachidonic acid producing strains of Yarrowia lipolytica |
US20060134301A1 (en) * | 2004-12-22 | 2006-06-22 | Unilever Bestfoods, North America, Division Of Conopco, Inc. | Method for making a food composition with a preservative free enhancer and a food composition |
US20060173070A1 (en) * | 2005-01-31 | 2006-08-03 | Kao Corporation | Method of enhancing motor function |
FI120616B (fi) * | 2005-02-18 | 2009-12-31 | Valio Oy | Vähäenergiainen, runsaasti kalsiumia sisältävä, rasvaton maitojuoma ja menetelmä sen valmistamiseksi |
EP1885453A4 (en) * | 2005-06-03 | 2011-06-29 | Horizon Science Pty Ltd | SUBSTANCES WITH BODY MASS DISTRIBUTION CHARACTERISTICS |
EP1888173A2 (en) * | 2005-06-07 | 2008-02-20 | DSMIP Assets B.V. | Novel use of (-)-epigallocatechin gallate |
US8945652B2 (en) | 2005-11-23 | 2015-02-03 | The Coca-Cola Company | High-potency sweetener for weight management and compositions sweetened therewith |
JP5707026B2 (ja) * | 2005-12-24 | 2015-04-22 | ディーエスエム アイピー アセッツ ビー.ブイ. | 長期体重維持 |
EP1997496B1 (en) | 2006-03-15 | 2015-07-29 | Suntory Holdings Limited | Composition containing riboflavin and sesamin-class compounds |
US7943823B2 (en) | 2006-04-28 | 2011-05-17 | E.I. Du Pont De Nemours And Company | Delta-8 desaturase and its use in making polyunsaturated fatty acids |
ATE410929T1 (de) * | 2006-07-24 | 2008-10-15 | Unilever Nv | Verbessertes getränk |
PL1891862T3 (pl) * | 2006-07-24 | 2012-08-31 | Unilever Nv | Prekursor napoju |
EP2064352B1 (en) * | 2006-09-19 | 2019-12-04 | The Product Makers (Australia) Pty Ltd | Extracts derived from sugar cane and a process for their manufacture |
US8501255B2 (en) * | 2006-12-14 | 2013-08-06 | Purac Biochem B.V. | Particulate composition comprising calcium lactate and calcium citrate microparticles |
WO2008071757A1 (en) * | 2006-12-14 | 2008-06-19 | Purac Biochem Bv | Particulate composition comprising calcium lactate and calcium citrate microparticles |
EP3342409A1 (en) | 2007-03-15 | 2018-07-04 | Suntory Holdings Limited | Anti-fatigue agent |
US20090087539A1 (en) * | 2007-10-01 | 2009-04-02 | Fry Ross G | Sustained energy drink |
US20210077517A1 (en) * | 2008-06-13 | 2021-03-18 | International IP Holdings | Edible Energy Composition |
US8158183B2 (en) * | 2008-12-15 | 2012-04-17 | Pepsico, Inc. | Unsaturated acids for fading protection of colors derived from natural sources used in beverage products |
JP5585055B2 (ja) * | 2009-11-16 | 2014-09-10 | 味の素株式会社 | 異風味が改善された飲用組成物 |
US8663714B2 (en) | 2009-11-26 | 2014-03-04 | D.Xign Limited | Appetite regulating dietary supplement |
US8476227B2 (en) | 2010-01-22 | 2013-07-02 | Ethicon Endo-Surgery, Inc. | Methods of activating a melanocortin-4 receptor pathway in obese subjects |
US9044606B2 (en) | 2010-01-22 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Methods and devices for activating brown adipose tissue using electrical energy |
AU2011222584B2 (en) * | 2010-03-05 | 2015-05-07 | Mars, Incorporated | Palatable beverages and compositions with cocoa extract |
ES2707816T3 (es) * | 2010-03-05 | 2019-04-05 | Mars Inc | Bebidas y composiciones proteínicas acidificadas |
WO2012106761A1 (en) | 2011-02-08 | 2012-08-16 | Horizon Science Pty Ltd | Sugar extracts |
KR101991746B1 (ko) * | 2011-10-04 | 2019-06-25 | (주)아모레퍼시픽 | 카테킨 생체 이용률 증진제 |
RU2525338C2 (ru) * | 2012-08-21 | 2014-08-10 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт питания РАМН" Российской академии медицинских наук (ФГБУ "НИИ питания" РАМН) | Инстантный функциональный пищевой продукт |
EA031427B1 (ru) | 2012-08-28 | 2018-12-28 | Дзе Продакт Мэйкерз (Острэйлиа) Пти Лтд | Способ получения экстракта, извлекаемого из сахарного тростника, и экстракт |
KR101974442B1 (ko) * | 2012-11-30 | 2019-05-03 | (주)아모레퍼시픽 | 사이클로덱스트린을 포함하는 카테킨 생체 이용률 증진제 |
US10952458B2 (en) | 2013-06-07 | 2021-03-23 | Purecircle Usa Inc | Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier |
PL3003058T5 (pl) | 2013-06-07 | 2023-12-04 | Purecircle Usa Inc. | Ekstrakt z stewii zawierający wybrane glikozydy stewiolowe jako modyfikator profilu smakowego, słonego i słodkiego |
WO2015021512A1 (en) | 2013-08-16 | 2015-02-19 | Horizon Science Pty Ltd | Sugar cane derived extracts and methods of treatment |
US10092738B2 (en) | 2014-12-29 | 2018-10-09 | Ethicon Llc | Methods and devices for inhibiting nerves when activating brown adipose tissue |
US10080884B2 (en) | 2014-12-29 | 2018-09-25 | Ethicon Llc | Methods and devices for activating brown adipose tissue using electrical energy |
EP3381451A4 (en) * | 2015-08-28 | 2019-10-09 | Caliway Biopharmaceuticals Co., Ltd. | PHARMACEUTICAL COMPOSITION FOR REDUCING LOCALIZED FAT AND USE OF THE PHARMACEUTICAL COMPOSITION |
US11318110B2 (en) | 2015-08-28 | 2022-05-03 | Caliway Biopharmaceuticals Co., Ltd. | Pharmaceutical composition for reducing local fat and uses thereof |
US20170119023A1 (en) * | 2015-10-30 | 2017-05-04 | Medtech Products Inc. | Soluble Fiber Liquid Beverage Concentrate And Method For Delivery Of Soluble Fiber |
EP3520627A4 (en) * | 2016-09-30 | 2020-06-03 | Kirin Holdings Kabushiki Kaisha | LOW-CARBONATED PRESSED CARROT JUICE AND CARROT-BASED DRINK |
KR101886802B1 (ko) * | 2017-12-18 | 2018-08-08 | (주)아모레퍼시픽 | 카테킨 생체 이용률 증진제 |
CA3106831C (en) * | 2019-01-23 | 2021-08-17 | Mizkan Holdings Co., Ltd. | Dried powder of edible plant, food and beverage, and production method therefor |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI85795C (fi) * | 1990-10-18 | 1992-06-10 | Huhtamaeki Oy | Foerfarande foer framstaellning av en haord i huvudsak sockeralkohol och riktigt xylitol innehaollande soetsaksprodukt. |
US5204115A (en) * | 1990-12-12 | 1993-04-20 | Suomen Xyrofin Oy | Directly compressible xylitol and method |
US5612026A (en) * | 1996-01-25 | 1997-03-18 | The Procter & Gamble Company | Cholesterol lowering drink mix compositons |
US5670344A (en) * | 1996-02-02 | 1997-09-23 | The Procter & Gamble Company | Preventing undesired color formation in iron fortified chocolate-flavored beverages by including edible acids or their salts |
US20020132780A1 (en) * | 2001-01-12 | 2002-09-19 | Heisey Matthew Thomas | Low carbohydrate compositions, kits thereof, and methods of use |
US7182968B2 (en) * | 2001-01-11 | 2007-02-27 | Fran Gare | Composition containing xylitol and fiber |
US20020187219A1 (en) * | 2001-03-29 | 2002-12-12 | The Procter & Gamble Co. | Low glycemic response compositions |
WO2002080850A2 (en) * | 2001-04-09 | 2002-10-17 | Danisco Usa, Inc. | Bulking agents as satiety agents |
-
2004
- 2004-05-17 JP JP2006508179A patent/JP2006526398A/ja active Pending
- 2004-05-17 AT AT04733339T patent/ATE440509T1/de not_active IP Right Cessation
- 2004-05-17 DE DE602004022806T patent/DE602004022806D1/de not_active Expired - Lifetime
- 2004-05-17 WO PCT/EP2004/005272 patent/WO2004110175A1/en active Application Filing
- 2004-05-17 US US10/559,351 patent/US20060121158A1/en not_active Abandoned
- 2004-05-17 CN CNA200480017407XA patent/CN1809288A/zh active Pending
- 2004-05-17 PL PL04733339T patent/PL1633209T3/pl unknown
- 2004-05-17 EP EP04733339A patent/EP1633209B1/en not_active Expired - Lifetime
- 2004-05-17 ES ES04733339T patent/ES2329370T3/es not_active Expired - Lifetime
- 2004-05-25 MY MYPI20041996A patent/MY141796A/en unknown
- 2004-06-01 TW TW093115654A patent/TWI293021B/zh not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104812253A (zh) * | 2012-11-29 | 2015-07-29 | 雀巢产品技术援助有限公司 | 用具有低血糖指数的碳水化合物增加黄烷-3-醇的生物利用度 |
CN104812253B (zh) * | 2012-11-29 | 2019-03-29 | 雀巢产品技术援助有限公司 | 用具有低血糖指数的碳水化合物增加黄烷-3-醇的生物利用度 |
Also Published As
Publication number | Publication date |
---|---|
WO2004110175A1 (en) | 2004-12-23 |
US20060121158A1 (en) | 2006-06-08 |
EP1633209A1 (en) | 2006-03-15 |
EP1633209B1 (en) | 2009-08-26 |
ES2329370T3 (es) | 2009-11-25 |
JP2006526398A (ja) | 2006-11-24 |
PL1633209T3 (pl) | 2009-12-31 |
ATE440509T1 (de) | 2009-09-15 |
WO2004110175A8 (en) | 2006-01-26 |
TW200427416A (en) | 2004-12-16 |
MY141796A (en) | 2010-06-30 |
TWI293021B (en) | 2008-02-01 |
DE602004022806D1 (de) | 2009-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1809288A (zh) | 体重管理饮料 | |
TWI360395B (en) | Acid prothin food with mineral | |
CN101453912B (zh) | 浸泡可可组合物以及由其制造的功能性可可饮料 | |
CN1589134A (zh) | 包括定义的硼化合物的组合物和套盒,其制备方法及其使用和给药 | |
JP5110314B2 (ja) | 睡眠改善用組成物及び睡眠改善剤 | |
KR100852416B1 (ko) | 박과 식초 조성물 | |
JP4394649B2 (ja) | 甘藷酢飲料及びその製造方法 | |
CN101766715B (zh) | 解酒醒酒组合物 | |
WO2014000403A1 (zh) | 银杏复合保健饮品的制造方法 | |
JP5120553B2 (ja) | 健康飲料 | |
CN101766672B (zh) | 解酒醒酒组合物 | |
KR20130130131A (ko) | 흑마늘 발효 식초 조성물 및 그 제조방법 | |
KR101350046B1 (ko) | 항비만 효능을 갖는 복합 생약 발효 식초 조성물 및 그 제조방법 | |
CN105707620A (zh) | 一种营养组合物饮品及其制备方法 | |
KR20110131518A (ko) | 해조류를 활용한 비만억제 식음료 제조방법 | |
CN101053364A (zh) | 绿茶雪糕 | |
KR20140017933A (ko) | 당뇨병 개선 효과능이 있는 탱자 발효 조성물 | |
CN101766717B (zh) | 解酒醒酒组合物 | |
RU2363268C1 (ru) | Биологически активная добавка к пище | |
KR20160050560A (ko) | 생마늘 식초 및 이 제조 방법 | |
KR102557893B1 (ko) | 농촌 고령 농민을 위한 블랙베리 앤 사과 스무디의 제조방법 | |
CN103458712A (zh) | 获得包含添加的水果香料的富含纤维和维生素的饮料的工艺以及从这一工艺获得的饮料 | |
KR100540498B1 (ko) | 아스타잔틴 및 아스파라긴산을 함유하는 숙취해소제 | |
CN101766716B (zh) | 解酒醒酒组合物 | |
CN108514123A (zh) | 从毛蚶提取的活性多肽制备复配物方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20060726 |